Multidisciplinary Assessment is Critical for Soft Tissue Sarcoma

2 Views

07/18/23

Expert panelists William D. Tap, MD; Jonathan C. Trent, MD, PhD; Richard F. Riedel, MD; Victor M. Villalobos, MD, PhD; and Kristen N. Ganjoo, MD, describe communication with other specialists at the multidisciplinary tumor board when planning treatment for soft tissue sarcoma in the curative setting.